Global Transducer for Fetal Heart Rate market, Product (Ultrasound, Fetal Electrodes, Telemetry Devices, Accessories and Consumables), Portability (Portable Systems), Method (Invasive), Application (Antepartum), End User (Hospitals) – Industry Trends and Forecast to 2029
Transducer for Fetal Heart Rate Market Analysis and Size
The global transducer for fetal heart rate market is expected to witness significant growth during the forecast period. Increasing prevalence of cardiopulmonary diseases, technological advancement such as noninvasive surgeries boost the market growth. Healthcare companies are focusing on developing systems that is suitable for clinicians and patients. Wearable devices are acquiring position in the fetal monitoring systems industry, due to their advantages in context to safer births and healthier children.
Data Bridge Market Research analyses a growth rate in the global transducer for fetal heart rate market in the forecast period 2022-2029. The expected CAGR of global transducer for fetal heart rate market is tend to be around 7.50% in the mentioned forecast period. The market was valued at USD 3.8 billion in 2021, and it would grow upto USD 6.78 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
An electronic transducer attached directly to the fetus's skin is used for internal fetal heart rate monitoring. Through the cervical hole, a wire electrode is affixed to the fetal scalp or other body portion and connected to the monitor. This type of electrode is also known as a spiral or scalp electrode. It has multiple applications in the healthcare industry today, thus rapidly increasing market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Ultrasound (3D & 4D), Fetal Electrodes, Telemetry Devices, Accessories and Consumables), Portability (Portable Systems), Method (Invasive), Application (Antepartum), End User (Hospitals)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hitachi, Ltd. (Japan), Siemens Healthcare GmbH (Germany), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), Samsung (South Korea), Analogic Corporation (U.S.), Esaote S.p.A (Italy), Carestream Health (U.S.), CURA Healthcare (India), Chison Medical Technologies Co., Ltd. (China), Mobisante, Inc. (U.S.), Neusoft Corporation (China), Clarius (Canada), MEDGYN PRODUCTS, INC. (U.S.), and Shanghai United Imaging Healthcare Co., Ltd. (China)
|
|
Market Opportunities
|
|
Global Transducer for Fetal Heart Rate Market Dynamics
Drivers
- Adoption of Noninvasive transducers
Leading manufacturers in the fetal monitoring market are expanding their product line with accurate, safe and affordable portable and wireless monitoring systems. Leading players on the market are also integrating telecom into these devices. For example, in 2020, Philips launched the handheld and telescopic ultrasound solution Lumify in Japan and the Avalon CL in the United States. Similarly, a strategic collaboration between MindChild Medical and Henry Schein Medical expanded sales and supply of the MERIDIAN M110 Fetal Monitoring System, a non-invasive delivery monitor in the United States in 2019.
Opportunities
- Technological Advancements
The importance of non-invasive monitoring techniques has shown much growth as a result of many R&D activities in foetal monitoring systems. Several technologies for noninvasive diagnostics have been launched such as foetal acid-base status, cell-free foetal DNA analysis, Doppler investigations, and electronic foetal monitoring (EFM) for the betterment of the patients. the technique of percutaneous umbilical cord blood sampling is used for prenatal foetal and neonatal examinations, and foetal scalp blood sampling is used for postpartum foetal and neonatal assessments. For improving the efficiency of foetal motor data processing, several advanced mathematical models, data analytics that are still in development stage, and classification and processing algorithms are all being researched and developed actively.
- Ease of Central and Bedside Fetal Surveillance Systems
The market for foetal monitoring devices is surrounded by the trend of central and bedside foetal observation and documentation. This is clear given that the market for foetal monitoring systems is anticipated to be led by hospitals and nursing homes. By the end of 2027, the market for foetal monitoring equipment would reportedly be worth US$3.8 billion. As a result, businesses and clinicians are collaborating closely to build cutting-edge foetal monitoring devices.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these devices could curb the growth of the global transducer for fetal heart rate market over a forecast period.
- High Cost
High cost of these devices can hinder the growth of the global transducer for fetal heart rate market.
This global transducer for fetal heart rate market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global transducer for fetal heart rate market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Transducer for Fetal Heart Rate Market Scope
The global transducer for fetal heart rate market is segmented on the basis of country, product, portability, method, application, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Ultrasound
- Fetal Electrodes
- Telemetry Devices
- Accessories and Consumables
Portability
- Portable Systems
Method
- Invasive
Application
- Antepartum
End User
- Hospitals
Global Transducer for Fetal Heart Rate Market Regional Analysis/Insights
The global transducer for fetal heart rate market is analysed and market size insights and trends are provided by country, product, portability, method, application, end user as referenced above.
The major countries covered in the global transducer for fetal heart rate market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is the dominating region in the global transducer for fetal heart rate market due to the presence of an established reimbursement structure coupled with availability of experts in the North American countries.
Meanwhile, the Asia-Pacific region has shown significant growth in the global transducer for fetal heart rate market due to per capita income, constant development in healthcare infrastructure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Transducer for Fetal Heart Rate Market Share Analysis
The global transducer for fetal heart rate market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global transducer for fetal heart rate market
Key players operating in the global transducer for fetal heart rate market include:
- General Electric (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Hitachi, Ltd. (Japan)
- Siemens Healthcare GmbH (Germany)
- Hologic, Inc. (U.S.)
- FUJIFILM Holdings Corporation (Japan)
- Samsung (South Korea)
- Analogic Corporation (U.S.)
- Esaote S.p.A (Italy)
- Carestream Health (U.S.)
- CURA Healthcare (India)
- Chison Medical Technologies Co., Ltd. (China)
- Mobisante, Inc. (U.S.)
- Neusoft Corporation (China)
- Clarius (Canada)
- MEDGYN PRODUCTS, INC. (U.S.)
- Shanghai United Imaging Healthcare Co., Ltd. (China)
SKU-